ACCELERON PHARMA INC Insider Trading for October 2016

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ACCELERON PHARMA INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in ACCELERON PHARMA INC for October 2016.

<<< Back to the month list

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...Option ExerciseM27.974,550127,26431,850
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...Option ExerciseM24.118,101195,31516,689
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...Option ExerciseM7.124,18229,776937
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...Option ExerciseM24.114,210101,50324,790
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...Option ExerciseM7.122,38116,9535,119
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...Option ExerciseM5.281,1155,88716,761
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...Option ExerciseM5.2810,98457,9960
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...Option ExerciseM3.889543,7024,561
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...Option ExerciseM5.287,12437,61517,876
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS34.1416,833574,67975,86692.7 K to 75.9 K (-18.16 %)
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...BuyM27.974,550127,26492,69988.1 K to 92.7 K (+5.16 %)
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...BuyM24.118,101195,31588,14980 K to 88.1 K (+10.12 %)
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...BuyM7.124,18229,77680,04875.9 K to 80 K (+5.51 %)
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS34.002895275,86675.9 K to 75.9 K (-0.04 %)
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS33.3719,616654,58675,89495.5 K to 75.9 K (-20.54 %)
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...BuyM24.114,210101,50395,51091.3 K to 95.5 K (+4.61 %)
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...BuyM7.122,38116,95391,30088.9 K to 91.3 K (+2.68 %)
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...BuyM5.281,1155,88788,91987.8 K to 88.9 K (+1.27 %)
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...BuyM5.2810,98457,99687,80476.8 K to 87.8 K (+14.30 %)
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...BuyM3.889543,70276,82075.9 K to 76.8 K (+1.26 %)
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS34.981,56154,60475,86677.4 K to 75.9 K (-2.02 %)
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS34.3114,448495,71177,42791.9 K to 77.4 K (-15.73 %)
Oct 11 2016XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...BuyM5.287,12437,61591,87584.8 K to 91.9 K (+8.41 %)
Oct 04 2016XLRNACCELERON PHARMA I ...George JeanDirectorSellS35.50857,14530,428,648453,5051.3 M to 453.5 K (-65.40 %)